Structural studies of Parvoviridae capsid assembly and evolution: implications for novel AAV vector design

Heather A Noriega1, Qizhao Wang2, Daozhan Yu2

  • 1Department of Pharmaceutical Sciences, Artificial Intelligence and Drug Discovery Core Laboratory for District of Columbia Center for AIDS Research (DC CFAR), College of Pharmacy, Howard University, Washington, DC, United States.

Summary

Computational methods enhance adeno-associated virus (AAV) vectors for gene therapy. Engineering AAV capsids improves treatment effectiveness and safety for genetic disorders, paving the way for personalized medicine.